BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17721792)

  • 1. Cancer-associated retinopathy (CAR) with electronegative ERG: a case report.
    Goetgebuer G; Kestelyn-Stevens AM; De Laey JJ; Kestelyn P; Leroy BP
    Doc Ophthalmol; 2008 Jan; 116(1):49-55. PubMed ID: 17721792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typical electronegative electroretinography and nyctalopia as a presenting feature of systemic malignant melanoma.
    Vercio A; Chalam KV; Winter T
    Int Med Case Rep J; 2019; 12():265-276. PubMed ID: 31496836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
    Karatsai E; Robson AG; Taylor SRJ
    JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung.
    Dot C; Guigay J; Adamus G
    Am J Ophthalmol; 2005 Apr; 139(4):746-7. PubMed ID: 15808190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of paraneoplastic retinopathy.
    Oohira A; Tamaki Y; Nagahara K; Nakanishi N
    Jpn J Ophthalmol; 1993; 37(1):28-31. PubMed ID: 8320862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunological characterization of paraneoplastic retinopathy.
    Makiyama Y; Kikuchi T; Otani A; Oishi A; Guo C; Nakagawa S; Ogino K; Kojima H; Kurimoto M; Yoshimura N
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5424-31. PubMed ID: 23860756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical triad to diagnose paraneoplastic retinopathy.
    Jacobson DM; Thirkill CE; Tipping SJ
    Ann Neurol; 1990 Aug; 28(2):162-7. PubMed ID: 2171418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction.
    Anastasakis A; Dick AD; Damato EM; Spry PG; Majid MA
    Doc Ophthalmol; 2011 Aug; 123(1):59-63. PubMed ID: 21674222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy.
    Chen FK; Chew AL; Zhang D; Chen SC; Chelva E; Chandrasekera E; Koay EMH; Forrester J; McLenachan S
    Doc Ophthalmol; 2017 Jun; 134(3):227-235. PubMed ID: 28382556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
    Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen side effects, age-related macular degeneration (AMD) or cancer associated retinopathy (CAR)?
    Sadowski B; Kriegbaum C; Apfelstedt-Sylla E
    Eur J Ophthalmol; 2001; 11(3):309-12. PubMed ID: 11681514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma.
    Murphy MA; Thirkill CE; Hart WM
    J Neuroophthalmol; 1997 Jun; 17(2):77-83. PubMed ID: 9176775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral negative electroretinogram presenting as photophobia.
    Kido A; Ogino K; Miyake Y; Yanagida K; Kikuchi T; Yoshimura N
    Doc Ophthalmol; 2016 Aug; 133(1):71-9. PubMed ID: 27245454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinoma-associated retinopathy: a review with clinical examples].
    Sobottka B; Schlote T; Besch D; Djelebova T; Wilhelm H; Zrenner E
    Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choroidal neovascularization associated with cancer-associated retinopathy.
    Querques G; Thirkill CE; Hagege H; Soubrane G; Souied EH
    Acta Ophthalmol; 2010 Aug; 88(5):571-5. PubMed ID: 19141145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute zonal occult outer retinopathy.
    Lee AG; Prager TC
    Acta Ophthalmol Scand; 1996 Feb; 74(1):93-5. PubMed ID: 8689493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral cancer-associated retinopathy: diagnosis, serology and treatment.
    Roels D; Ueno S; Talianu CD; Draganova D; Kondo M; Leroy BP
    Doc Ophthalmol; 2017 Dec; 135(3):233-240. PubMed ID: 28815346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological evaluation of visual loss in Müller cell sheen dystrophy.
    Kellner U; Kraus H; Heimann H; Helbig H; Bornfeld N; Foerster MH
    Br J Ophthalmol; 1998 Jun; 82(6):650-4. PubMed ID: 9797666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed presentation of melanoma-associated retinopathy and subsequent resolution with cytoreduction surgery.
    Stead RE; Fox MA; Staples E; Lim CS
    Doc Ophthalmol; 2013 Oct; 127(2):165-71. PubMed ID: 23794161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome.
    Khan N; Huang JJ; Foster CS
    Semin Ophthalmol; 2006; 21(3):135-41. PubMed ID: 16912011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.